VIEX Capital Advisors’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-88,354
Closed -$194K 22
2019
Q2
$194K Sell
88,354
-96,329
-52% -$306K 0.15% 17
2019
Q1
$659K Sell
184,683
-81,378
-31% -$283K 0.58% 15
2018
Q4
$644K Buy
266,061
+87,280
+49% +$416K 0.56% 15
2018
Q3
$1.27M Sell
178,781
-4,454
-2% -$39.2K 1.1% 16
2018
Q2
$2.03M Sell
183,235
-91,570
-33% -$936K 1.7% 15
2018
Q1
$2.52M Buy
274,805
+1,320
+0.5% +$12.1K 1.65% 15
2017
Q4
$2.6M Buy
273,485
+34,547
+14% +$348K 1.58% 17
2017
Q3
$2.56M Buy
238,938
+18,389
+8% +$169K 1.09% 17
2017
Q2
$2.27M Buy
220,549
+53,566
+32% +$675K 1.26% 14
2017
Q1
$2.34M Buy
166,983
+15,481
+10% +$236K 1.82% 12
2016
Q4
$2.29M Buy
+151,502
New +$2.3M 1.44% 13

Other funds holding HHS

VIEX Capital Advisors's HHS Position: Q3 2019 in Review

VIEX Capital Advisors sold out of Harte-Hanks (HHS) in Q3 2019, closing a stake of 88,354 shares — an estimated $194K sold.

VIEX Capital Advisors first reported a position in HHS in Q4 2016 and held it in 11 quarters. The position peaked at $2.6M in Q4 2017. 24 funds tracked by Wall St. Rank hold HHS as of Q3 2019.

  • VIEX Capital Advisors reported no remaining Harte-Hanks position as of Q3 2019 after selling out during the quarter.
  • VIEX Capital Advisors sold 88,354 Harte-Hanks shares in Q3 2019, an estimated $194K.
  • VIEX Capital Advisors first reported a position in Harte-Hanks in Q4 2016 and held it in 11 quarters.
  • VIEX Capital Advisors's Harte-Hanks position peaked at $2.6M in Q4 2017.
  • 24 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2019.

Based on VIEX Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.